189 related articles for article (PubMed ID: 27553711)
1. Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.
Barreto FK; Khouri R; Rego FFA; Santos LA; Castro-Amarante MF; Bialuk I; Pise-Masison CA; Galvão-Castro B; Gessain A; Jacobson S; Franchini G; Alcantara LC
Infect Genet Evol; 2016 Nov; 45():420-425. PubMed ID: 27553711
[TBL] [Abstract][Full Text] [Related]
2. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome.
Beby-Defaux A; Frugier F; Bourgoin A; Moynet D; Hajjar C; Sainte-Foie S; Guillemain B; Agius G
J Med Virol; 1999 Oct; 59(2):245-55. PubMed ID: 10459164
[TBL] [Abstract][Full Text] [Related]
4. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E
J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661
[TBL] [Abstract][Full Text] [Related]
5. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
[TBL] [Abstract][Full Text] [Related]
7. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
8. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Matsuura E; Kodama D; Tashiro Y; Matsuzaki T; Kubota R; Izumo S; Takashima H
Retrovirology; 2017 Apr; 14(1):26. PubMed ID: 28420387
[TBL] [Abstract][Full Text] [Related]
9. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
[TBL] [Abstract][Full Text] [Related]
11. Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy.
Kira J; Koyanagi Y; Yamada T; Itoyama Y; Tateishi J; Akizuki S; Kishikawa M; Baba E; Nakamura M; Suzuki J
Ann Neurol; 1994 Aug; 36(2):149-56. PubMed ID: 8053650
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
[TBL] [Abstract][Full Text] [Related]
14. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
[TBL] [Abstract][Full Text] [Related]
15. Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers.
Martins ML; Soares BC; Ribas JG; Thorun GW; Johnson J; Kroon EG; Carneiro-Prioetti AB; Bonjardim CA;
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):899-902. PubMed ID: 12230932
[TBL] [Abstract][Full Text] [Related]
16. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
Ramirez E; Cartier L; Torres M; Barria M
J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
[TBL] [Abstract][Full Text] [Related]
17. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
18. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years.
Matsuzaki T; Nakagawa M; Nagai M; Usuku K; Higuchi I; Arimura K; Kubota H; Izumo S; Akiba S; Osame M
J Neurovirol; 2001 Jun; 7(3):228-34. PubMed ID: 11517397
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.
Mota-Miranda AC; Barreto FK; Amarante MF; Batista E; Monteiro-Cunha JP; Farre L; Galvão-Castro B; Alcantara LC
Virol J; 2013 Mar; 10():75. PubMed ID: 23510700
[TBL] [Abstract][Full Text] [Related]
20. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.
Nagai M; Usuku K; Matsumoto W; Kodama D; Takenouchi N; Moritoyo T; Hashiguchi S; Ichinose M; Bangham CR; Izumo S; Osame M
J Neurovirol; 1998 Dec; 4(6):586-93. PubMed ID: 10065900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
